These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29282034)

  • 1. Outcome of breast cancer screening in Denmark.
    Lynge E; Bak M; von Euler-Chelpin M; Kroman N; Lernevall A; Mogensen NB; Schwartz W; Wronecki AJ; Vejborg I
    BMC Cancer; 2017 Dec; 17(1):897. PubMed ID: 29282034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
    Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
    Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
    Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
    Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
    Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.
    Bennett IC; Muller J; Cockburn L; Joshua H; Thorley G; Baker C; Wood N; Brazier J; Jones M; Dunn N; Gattas M
    World J Surg; 2010 May; 34(5):979-86. PubMed ID: 20108093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014.
    Szynglarewicz B; Matkowski R
    Adv Clin Exp Med; 2017; 26(2):259-262. PubMed ID: 28791843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.